Leflunomide is approved as a dihydro-orotate dehydrogenase inhibitor used to treat rheumatoid arthritis and psoriatic arthritis [103]; teriflunomide was later approved for the treatment of multiple sclerosis [104]. Here, DHODH is linked to multiple sclerosis.